Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1971 3
1989 1
1990 1
1995 2
1996 2
1997 1
1998 4
1999 2
2002 1
2003 1
2005 3
2007 1
2008 1
2010 2
2011 1
2013 1
2016 4
2018 1
2019 2
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy.
Li JY, Perry SR, Muniz-Medina V, Wang X, Wetzel LK, Rebelatto MC, Hinrichs MJ, Bezabeh BZ, Fleming RL, Dimasi N, Feng H, Toader D, Yuan AQ, Xu L, Lin J, Gao C, Wu H, Dixit R, Osbourn JK, Coats SR. Li JY, et al. Among authors: osbourn jk. Cancer Cell. 2016 Jan 11;29(1):117-29. doi: 10.1016/j.ccell.2015.12.008. Cancer Cell. 2016. PMID: 26766593 Free article.
Community crystal gazing.
Acharya A, Bingham K, Bradner J, Burke W, Charo RA, Cherry J, Choulika A, Coles T, Cook-Deegan R, Crooke ST, Díaz E, Erickson B, Giddings LV, Giwa SE, Greenwood JC, Gulati V, Hall S, Harris J, Heywood J, Hill C, Levin J, Mangubat A, Maraganore J, Mariggi G, Mazur BJ, McGuire AL, Moll N, Moreno J, Naughton G, Nelsen L, Osbourn J, Perez D, Reed J, Schmidt E, Seyfert-Margolis V, Stoffels P, Thorball J, O'Toole T, Vainu I, van Deventer S, Zerhouni E, Zohar D. Acharya A, et al. Among authors: osbourn j. Nat Biotechnol. 2016 Mar;34(3):276-83. doi: 10.1038/nbt.3515. Nat Biotechnol. 2016. PMID: 26963550 No abstract available.
Human antibodies by design.
Vaughan TJ, Osbourn JK, Tempest PR. Vaughan TJ, et al. Among authors: osbourn jk. Nat Biotechnol. 1998 Jun;16(6):535-9. doi: 10.1038/nbt0698-535. Nat Biotechnol. 1998. PMID: 9624683 Review.
Proximity-guided (ProxiMol) antibody selection.
Osbourn JK. Osbourn JK. Methods Mol Biol. 2002;178:201-5. doi: 10.1385/1-59259-240-6:201. Methods Mol Biol. 2002. PMID: 11968489 Review. No abstract available.
Erratum: Community crystal gazing.
Acharya A, Bingham K, Bradner J, Burke W, Charo RA, Cherry J, Choulika A, Coles T, Cook-Deegan R, Crook ST, Díaz E, Erickson B, Giddings LV, Giwa SE, Greenwood JC, Gulati V, Hall S, Harris J, Heywood J, Hill C, Levin J, Mangubat A, Maraganore J, Mariggi G, Mazur BJ, McGuire AL, Moll N, Moreno J, Naughton G, Nelsen L, Osbourn J, Perez D, Reed J, Schmidt E, Seyfert-Margolis V, Stoffels P, Thorball J, O'Toole T, Vainu I, van Deventer S, Zerhouni E, Zohar D. Acharya A, et al. Among authors: osbourn j. Nat Biotechnol. 2016 Jun 9;34(6):666. doi: 10.1038/nbt0616-666d. Nat Biotechnol. 2016. PMID: 27281427 No abstract available.
Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses.
Bullen G, Galson JD, Hall G, Villar P, Moreels L, Ledsgaard L, Mattiuzzo G, Bentley EM, Masters EW, Tang D, Millett S, Tongue D, Brown R, Diamantopoulos I, Parthiban K, Tebbutt C, Leah R, Chaitanya K, Ergueta-Carballo S, Pazeraitis D, Surade SB, Ashiru O, Crippa L, Cowan R, Bowler MW, Campbell JI, Lee WJ, Carr MD, Matthews D, Pfeffer P, Hufton SE, Sawmynaden K, Osbourn J, McCafferty J, Karatt-Vellatt A. Bullen G, et al. Among authors: osbourn j. Front Immunol. 2021 Jun 15;12:678570. doi: 10.3389/fimmu.2021.678570. eCollection 2021. Front Immunol. 2021. PMID: 34211469 Free PMC article.
Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures.
Galson JD, Schaetzle S, Bashford-Rogers RJM, Raybould MIJ, Kovaltsuk A, Kilpatrick GJ, Minter R, Finch DK, Dias J, James LK, Thomas G, Lee WJ, Betley J, Cavlan O, Leech A, Deane CM, Seoane J, Caldas C, Pennington DJ, Pfeffer P, Osbourn J. Galson JD, et al. Among authors: osbourn j. Front Immunol. 2020 Dec 15;11:605170. doi: 10.3389/fimmu.2020.605170. eCollection 2020. Front Immunol. 2020. PMID: 33384691 Free PMC article.
Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment.
Chodorge M, Celeste AJ, Grimsby J, Konkar A, Davidsson P, Fairman D, Jenkinson L, Naylor J, White N, Seaman JC, Dickson K, Kemp B, Spooner J, Rossy E, Hornigold DC, Trevaskis JL, Bond NJ, London TB, Buchanan A, Vaughan T, Rondinone CM, Osbourn JK. Chodorge M, et al. Among authors: osbourn jk. Sci Rep. 2018 Dec 3;8(1):17545. doi: 10.1038/s41598-018-35869-4. Sci Rep. 2018. PMID: 30510163 Free PMC article.
39 results